Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ekman

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Lakartidningen|November 4, 1992
[Drug therapy of benign prostatic hyperplasia]P Ekman
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1981
Steroid receptors in urological malignanciesP Ekman
Psychological Review|July 1, 1992
Are there basic emotions?P Ekman
Journal D'Urologie|January 1, 1995
Endocrine therapy for benign prostatic hyperplasia in the 90'sP Ekman
Archivos Espanoles De Urologia|November 1, 1994
Pharmacological treatment of benign prostatic hyperplasia with finasteride: a clinical reviewP Ekman
Science (New York, N.Y.)|August 15, 1980
Asymmetry in facial expressionP Ekman
Scandinavian Journal of Urology and Nephrology|January 1, 1982
Single drug therapy in non-seminomatous germinal cell tumours of the testicleP Ekman
The Prostate. Supplement|January 1, 1989
BPH epidemiology and risk factorsP Ekman
Drug Safety|April 8, 1998
A risk-benefit assessment of treatment with finasteride in benign prostatic hyperplasiaP Ekman
European Urology|April 29, 1998
Maximum efficacy of finasteride is obtained within 6 months and maintained over 6 years. Follow-up of the Scandinavian Open-Extension Study. The Scandinavian Finasteride Study GroupP Ekman
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Lakartidningen|November 4, 1992
[Drug therapy of benign prostatic hyperplasia]P Ekman
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1981
Steroid receptors in urological malignanciesP Ekman
Psychological Review|July 1, 1992
Are there basic emotions?P Ekman
Journal D'Urologie|January 1, 1995
Endocrine therapy for benign prostatic hyperplasia in the 90'sP Ekman
Archivos Espanoles De Urologia|November 1, 1994
Pharmacological treatment of benign prostatic hyperplasia with finasteride: a clinical reviewP Ekman
Science (New York, N.Y.)|August 15, 1980
Asymmetry in facial expressionP Ekman
Scandinavian Journal of Urology and Nephrology|January 1, 1982
Single drug therapy in non-seminomatous germinal cell tumours of the testicleP Ekman
The Prostate. Supplement|January 1, 1989
BPH epidemiology and risk factorsP Ekman
Drug Safety|April 8, 1998
A risk-benefit assessment of treatment with finasteride in benign prostatic hyperplasiaP Ekman
European Urology|April 29, 1998
Maximum efficacy of finasteride is obtained within 6 months and maintained over 6 years. Follow-up of the Scandinavian Open-Extension Study. The Scandinavian Finasteride Study GroupP Ekman
Pageof 19